Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa

J Bacteriol. 2010 Apr;192(7):1921-8. doi: 10.1128/JB.01459-09. Epub 2010 Jan 29.

Abstract

Pseudomonas aeruginosa produces three different types of bacteriocins: the soluble S-pyocins and the bacteriophage-like F- and R-pyocins. R-pyocins kill susceptible bacteria of the same or closely related species with high efficiency. Five different types of R-pyocins (R1- to R5-pyocins) have been described based on their killing spectra and tail fiber protein sequences. We analyzed the distribution of R-pyocin genes in a collection of clinical P. aeruginosa isolates. We found similar percentages of isolates not containing R-pyocins (28%) and isolates containing genes encoding R1-pyocins (25%), R2-pyocins (17%), and R5-pyocins (29%). The R-pyocin-deficient isolates were susceptible to R1-, R2-, and R5-pyocins, while most R2- and R5- pyocin producers were resistant. Determination of the O serotypes revealed that the R-pyocin-susceptible isolates belonged to serotypes O1, O3, and O6, while the R-pyocin-resistant isolates were serotype O10, O11, and O12 isolates. We hypothesized that O-serotype-specific lipopolysaccharide (LPS) packaging densities may account for the distinct accessibilities of R-pyocins to their receptors at the cell surface. Using genetically defined LPS mutants, we showed that the l-Rha residue and two distinct d-Glc residues of the outer core are part of the receptor sites for R1-, R2-, and R5-pyocins, respectively. To illustrate R-pyocin-mediated intraspecies biological warfare, we monitored the population dynamics of two different R-pyocin-producing P. aeruginosa clones of sequential respiratory isolates obtained from a colonized patient. The results of this study highlight the potential role of R-pyocins in shaping bacterial populations during host colonization and support use of these molecules as specific and potent bactericidal agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / toxicity*
  • Antibiosis
  • Humans
  • Lipopolysaccharides / chemistry
  • Lipopolysaccharides / genetics
  • Lipopolysaccharides / metabolism*
  • Models, Molecular
  • Mutation
  • O Antigens / analysis
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / genetics
  • Pseudomonas aeruginosa / isolation & purification
  • Pseudomonas aeruginosa / physiology*
  • Pyocins / metabolism
  • Pyocins / toxicity*
  • Serotyping

Substances

  • Anti-Bacterial Agents
  • Lipopolysaccharides
  • O Antigens
  • Pyocins